药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tasosartan
Hydroxytyrosol
The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Palbociclib.
Tasosartan
Butylphthalide
The risk or severity of bleeding can be increased when Butylphthalide is combined with Palbociclib.
Tasosartan
Indobufen
The risk or severity of bleeding can be increased when Indobufen is combined with Palbociclib.
Tasosartan
Ketanserin
The risk or severity of bleeding can be increased when Ketanserin is combined with Palbociclib.
Tasosartan
Nitroaspirin
The risk or severity of bleeding can be increased when Nitroaspirin is combined with Palbociclib.
Tasosartan
Ifetroban
The risk or severity of bleeding can be increased when Ifetroban is combined with Palbociclib.
Tasosartan
Sarpogrelate
The risk or severity of bleeding can be increased when Sarpogrelate is combined with Palbociclib.
Tasosartan
Trapidil
The risk or severity of bleeding can be increased when Trapidil is combined with Palbociclib.
Tasosartan
Icosapent ethyl
The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Palbociclib.
Tasosartan
Triflusal
The risk or severity of bleeding can be increased when Triflusal is combined with Palbociclib.
Tasosartan
Cangrelor
The risk or severity of bleeding can be increased when Cangrelor is combined with Palbociclib.
Tasosartan
Prasugrel
The risk or severity of bleeding can be increased when Prasugrel is combined with Palbociclib.
Tasosartan
Caplacizumab
The risk or severity of bleeding can be increased when Caplacizumab is combined with Palbociclib.
Tasosartan
Andrographolide
The risk or severity of bleeding can be increased when Andrographolide is combined with Palbociclib.
Tasosartan
Ibudilast
The risk or severity of bleeding can be increased when Ibudilast is combined with Palbociclib.
Tasosartan
Beraprost
The risk or severity of bleeding can be increased when Beraprost is combined with Palbociclib.
Tasosartan
Defibrotide
The risk or severity of bleeding can be increased when Defibrotide is combined with Palbociclib.
Tasosartan
Moderna COVID-19 Vaccine
The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Palbociclib.
Tasosartan
Ebola Zaire vaccine (live, attenuated)
The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Palbociclib.
Tasosartan
Modified vaccinia ankara
The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Palbociclib.